CD8A and neoplasm: However, this secretion has no immediate impact on T cell killing activity, since both ovalbumin (OVA)-expressing FGL2KO and control tumor cells had the same sensitivity to cell killing by OVA peptide-activated CD8+ T cells (OT-I) in vitro (Supplementary Figure 5c).